Green light hps laser vs transurethral resection of the prostate for the treatment of benign prostatic hyperplasia

Background: BPH is the major etiology of lower urinary tract symptoms (LUTS) in men >50 years of age. In our study, we described our institutional prospective study comparing the efficacy and outcomes of Greenlight laser photovaporisation of prostate (PVP) and transurethral resection of prostate (TURP) for the treatment of benign prostatic hyperplasia (BPH). Aims and objectives: To study and compare prospectively, study complications & their management and surgical treatments modalities in high risk patients outcome ofPVP and TURP. Materials and methods: The prospective study was conducted between September 2019 and August 2022, at department of Surgery, Nootan Medical College & Research Centre, Visnagar. A total of 150 patients with BPH were enrolled in the study. 75 patients underwent PVP and 75 patients underwent TURP. Out of 75 TURP patients, 38 patients underwent monopolar TURP and rest 37 underwent bipolar TURP. Results and discussion: Average age for PVP is 67.9 years, 64.02 years for monopolar TURP is and 66.15 years for bipolar TURP. Mean operative time for PVP is 46.68 min, 38.55 min for monopolar TURP and 38.37minfor bipolar TURP. Transient dysuria is found in 6% in PVP, 1% in monopolar and 0% in bipolar, TUR syndrome and blood transfusion is 0% in patients undergoing PVP. Conclusions: PVP might be considered as safe and effective surgical procedure for the treatment of patients with BPH at high risk such as heart disease, diabetes mellitus, hypertension, COPD and cerebrovascular accident. Duration of surgery is longer in PVP but complications such as TUR syndrome, blood transfusion, capsular perforations, clot retention and urethral stricture are lower in PVP